Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds

The transcription factor FOXM1 is upregulated and overexpressed in aggressive, therapy-resistant forms of hormone receptor-positive and triple negative breast cancers, and is associated with less good patient survival. FOXM1 signaling is also a key driver in many other cancers. Here, we identify a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziegler, Yvonne, Laws, Mary J., Sanabria Guillen, Valeria, Kim, Sung Hoon, Dey, Parama, Smith, Brandi P., Gong, Ping, Bindman, Noah, Zhao, Yuechao, Carlson, Kathryn, Yasuda, Mayuri A., Singh, Divya, Li, Zhong, El-Ashry, Dorraya, Madak-Erdogan, Zeynep, Katzenellenbogen, John A., Katzenellenbogen, Benita S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884575/
https://www.ncbi.nlm.nih.gov/pubmed/31815181
http://dx.doi.org/10.1038/s41523-019-0141-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884575/
https://www.ncbi.nlm.nih.gov/pubmed/31815181
http://dx.doi.org/10.1038/s41523-019-0141-7

Ejemplares similares